Abstract
The objective of this study was to regulate the cytotoxicity of cisplatin (cisPt) minimizing its adverse effects. For this purpose, the lowest cisPt concentration needed to obtain a significant positive response in cutaneous squamous cell carcinoma (cSCC) was explored. Two adjuvant agents as gold nanoparticles (AuNP) and chelating tricine were tested as enhancers in cisPt treatment. Effectiveness of all treatments was assessed by means of biochemical techniques, which offer quantitative data, as well as two microscopy-based techniques that provided qualitative cell imaging. The present work confirms the effectiveness of free cisplatin at very low concentrations. In order to enhance its effectiveness while the side effects were probably diminished, cisPt 3.5 μM was administered with AuNP 2.5 mM, showing an effectiveness practically equal to that observed with free cisPt. However, the second treatment investigated, based on cisPt 3.5 μM combined with tricine 50 mM, enhanced drug effectiveness, increasing the percentage of cells dying by apoptosis. This treatment was even better in terms of cell damage than free cisPt at 15 μM. Images obtained by TEM and cryo-SXT confirmed these results, since a notable number of apoptotic bodies ...Continue Reading
References
Feb 1, 1966·Biochemistry·N E GoodR M Singh
Jan 1, 1996·Journal of Structural Biology·J R KremerJ R McIntosh
Sep 1, 1995·Bioconjugate Chemistry·S K LarsenM J Abrams
Jul 2, 1999·Biophysical Journal·O Keminer, R Peters
Feb 15, 2001·Acta Crystallographica. Section C, Crystal Structure Communications·M Ramos SilvaL Alte da Veiga
Jun 19, 2001·Mutation Research·M Kartalou, J M Essigmann
Dec 26, 2001·Chemical Reviews·E R Jamieson, S J Lippard
Jun 5, 2003·Expert Opinion on Pharmacotherapy·Jörg Thomas Hartmann, Hans-Peter Lipp
Dec 4, 2003·Journal of Structural Biology·José Jesús Fernández, Sam Li
Jul 21, 2004·Journal of Computational Chemistry·Eric F PettersenThomas E Ferrin
Mar 25, 2005·Nature Reviews. Drug Discovery·Dong Wang, Stephen J Lippard
Jan 5, 2006·Genes & Development·Wei-Xing Zong, Craig B Thompson
Jul 13, 2007·Nature Reviews. Cancer·Lloyd Kelland
Jun 19, 2009·Journal of Synchrotron Radiation·E PereiroM R Howells
Jul 21, 2009·Journal of Structural Biology·José L CarrascosaGerd Schneider
Oct 7, 2009·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Silke TribiusDirk Rades
Aug 31, 2010·Journal of Comparative Pathology·C Rodríguez-CariñoJ Segalés
Dec 22, 2010·Bioinformatics·J I Agulleiro, J J Fernandez
May 3, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Joan ComengeVictor Puntes
Aug 24, 2012·Molecular Cancer Therapeutics·Zheng D LiangMacus Tien Kuo
Oct 20, 2012·PloS One·Joan ComengeVíctor F Puntes
Jul 3, 2015·Journal of Synchrotron Radiation·Andrea SorrentinoEva Pereiro
Jun 14, 2016·Dermatologic Therapy·S GilM Sabés
Jun 22, 2016·ACS Nano·Ana Joaquina Pérez-BernáPablo Gastaminza
Mar 7, 2019·The American Journal of Case Reports·Anita PandeyJames E O'Donnell